Little Rock, AR, United States of America

Timothy J O'Brien

This inventor holds 61 USPTO granted patents and 9 published patent applications and 4 EPO patents, primarily in Cancer Immunotherapy (CPC class C12N). Top assignees: University of Arkansas, Bioventures, LLC, Ic Therapeutics Inc.. Active years: 1990-2020.

USPTO Granted Patents = 61 (Patent Applications = 9)

% Patents Active = 41.0

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 660(Granted Patents)

Forward Citations (Not Self Cited) = 627(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Columbus, GA (US) (1999)
Anoka, MN (US) (2013 - 2015)
Little Rock, AR (US) (1990 - 2019)
St. Francis, MN (US) (2020)

Company Filing History:

51 out of 849

University of Arkansas

Research, Incorporated

patents

5. 1 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 7 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2020

Loading Chart...

Areas of Expertise:

Blood Sampling

Cancer Immunotherapy

Ovarian Cancer Diagnostics

Extracellular Serine Protease

Transmembrane Serine Protease

CA125 Gene

Dendritic Cell Activation

Monoclonal Antibodies

TADG-15 Protein

Quaternary Ammonium Compounds

Vascular Health

Physical Exercise Systems

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10631771 - Methods and apparatus for blood sampling (2020-04-28),

2. 10443039 - Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor (2019-10-15),

3. 9783795 - Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer (2017-10-10),

4. 9556245 - CA125 gene and its use for diagnostic and therapeutic interventions (2017-01-31),

5. 8956387 - Systems for replicating the beneficial effects of physical exercise and improving cardiovascular health (2015-02-17),

6. 8895703 - CA125 gene and its use for diagnostic and therapeutic interventions (2014-11-25),

7. 8609819 - Extracellular serine protease (2013-12-17),

8. 8551008 - Method and apparatus for determining vascular health conditions (2013-10-08),

9. 8546137 - Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor (2013-10-01),

10. 8323673 - Concentrated, non-foaming solution of quaternary ammonium compounds and methods of use (2012-12-04),

11. 8216794 - Extracellular serine protease (2012-07-10),

12. 8187587 - Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme (2012-05-29),

13. 8124728 - CA125 gene and its use for diagnostic and therapeutic interventions (2012-02-28),

14. 8088390 - Methods for the early diagnosis of ovarian cancer (2012-01-03),

15. 8057999 - Extracellular serine protease (2011-11-15),

Title: The Innovative Mind of Timothy J O'Brien

Introduction: Timothy J O'Brien, a talented inventor hailing from Little Rock, AR, has made significant contributions to the world of technology and innovation.

Latest Patents: Timothy J O'Brien holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Timothy has worked for leading tech companies, spearheading research and development projects that have resulted in cutting-edge inventions.

Collaborations: Timothy J O'Brien has collaborated with top researchers from renowned universities and research institutions, fostering a culture of innovation and pushing the boundaries of technological advancement.

Conclusion: In conclusion, Timothy J O'Brien's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in the realm of renewable energy technologies.